Chlorhexidine Gluconate 0012 For Manufacturing, Processing or Repacking, RX Only, Medichem, S.A. Poligono Industrial Celra, 17460, Celra, Girona (Spain/Espana); Fructuos Gelabert, 6-8, 08970, Sant Joan Despi, Barcelona (Spain/Espana) NDC 53296-0012-0
Published September 2, 2020 · Recall initiated: June 24, 2020
Summary
FDA records drug Class I recall D-1534-2020, published September 2, 2020 and initiated June 24, 2020. Recalling firm: Medichem S.A.; Status: Terminated; Reported quantity: 117,800 kg; Lot: A-190571, exp. 11/29/21, A-190418, exp. 09/04/21, A-190503, exp. 10/25/21, A-190576, exp. 12/02/21, A-190537, exp. 11/15/21, A-200082, exp. 02/24/22, A-200085, exp. 02/25/22, A-200097, exp. 03/05/22, A-200116, exp. 03/13/22, A-200127, exp. 03/19/22, A-200131, exp. 03/20/22. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Microbial contamination of Non-Sterile Product; detection of the gram-negative bacillus Serratia marcescens in certain API batches
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Medichem S.A.
- Distributor
- Nationwide
- Lot
- A-190571, exp. 11/29/21, A-190418, exp. 09/04/21, A-190503, exp. 10/25/21, A-190576, exp. 12/02/21, A-190537, exp. 11/15/21, A-200082, exp. 02/24/22, A-200085, exp. 02/25/22, A-200097, exp. 03/05/22, A-200116, exp. 03/13/22, A-200127, exp. 03/19/22, A-200131, exp. 03/20/22
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- Spain
Related recalls
- FDAChlorhexidine Gluconate 20% 0012 Medichem, S.A. NDC 53296-0012-0November 11, 2020
- FDABuprenorphine HCl Injection, 0.3 mg/mL, 1 mL vial, For Intramuscular or Intravenous Use Only, Rx Only,September 2, 2020
- FDASulfamethoxazole and Trimethoprim Tablets, USP, 800 mg/160 mg Double Strength, 500 Tablets per bottle, RxSeptember 2, 2020
- FDADexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg per 50 mL (4 mcg per mL), for intravenousSeptember 2, 2020
- FDAAlaris Syringe Module Model 8110 - Product Usage: is intended to provide trained healthcare caregivers a wayAugust 26, 2020
- FDAPositron Emission Tomography and Computed Tomography System, Model: uMI 550, Material Number: 88000057 -August 26, 2020
Questions about this recall
Was Chlorhexidine Gluconate 0012 For Manufacturing, Processing or Repacking, RX Only, Medichem, S.A. Poligono Industrial Celra, 17460, Celra, Girona (Spain/Espana); Fructuos Gelabert, 6-8, 08970, Sant Joan Despi, Barcelona (Spain/Espana) NDC 53296-0012-0 recalled?
Yes. FDA published recall D-1534-2020 on September 2, 2020. Reported hazard: Microbial contamination of Non-Sterile Product; detection of the gram-negative bacillus Serratia marcescens in certain API batches
What should I do if I have this product?
Voluntary: Firm initiated · Letter